Search For Lab Tests Here

The Alpha-Fetoprotein (AFP) and AFP-L3 Test measures total AFP and the AFP-L3 fraction, which is more specific for liver cancer risk. Elevated AFP may indicate liver disease, germ cell tumors, or hepatitis, while AFP-L3 is strongly associated with hepatocellular carcinoma (HCC). Doctors order this test to assess liver function, screen high-risk patients, and monitor cancer treatment. Results provide critical insight into liver health and cancer detection.

The CA 15-3 Test measures cancer antigen 15-3 levels in blood, often used to monitor breast cancer treatment and progression. Elevated levels may suggest advanced breast cancer, metastasis, or recurrence, while non-cancer conditions can also affect results. Doctors order this test alongside imaging and other labs to track therapy response or detect changes in disease status. Results help guide ongoing management of breast cancer and patient care.

The Lactate Dehydrogenase (LDH) Isoenzyme Panel measures total LDH and separates it into isoenzymes (LDH-1 to LDH-5) to identify tissue damage. LDH-1 is linked to heart, LDH-2 to blood, LDH-3 to lungs, LDH-4 to kidneys, and LDH-5 to liver and muscle. Elevated levels may indicate heart attack, liver disease, anemia, or cancer. Doctors order this test to pinpoint tissue injury, monitor disease progression, and guide treatment strategies.

The CA 125 Test measures the level of cancer antigen 125 in blood, a protein often elevated in ovarian cancer and some other conditions. While not used alone for diagnosis, it helps monitor treatment effectiveness, detect recurrence, or assess disease progression. Elevated CA 125 may also be seen in endometriosis, fibroids, or pelvic inflammation. Doctors use this test to support cancer management and track overall reproductive and abdominal health.

The CA 19-9 Test measures levels of carbohydrate antigen 19-9 in blood, a tumor marker often elevated in pancreatic cancer and sometimes in bile duct, colorectal, or liver cancers. While not used alone for diagnosis, it helps monitor treatment, track disease progression, and detect recurrence. Elevated CA 19-9 may also occur in noncancerous conditions. Doctors use this test to support cancer management and guide therapy decisions.

The Liver and Kidney Function Panel measures blood sugar, electrolytes, proteins, and markers of liver and kidney health. It helps detect disease, monitor conditions, and guide treatment decisions.

 The CA-2 Cancer Screening - Women panel is a specialized diagnostic tool designed for the early detection and ongoing monitoring of various cancers specifically in women. It expands upon basic cancer screening by including additional markers that provide a wider range of detection and insight into different types of cancers. This panel is particularly valuable for women who are at increased risk due to genetic predispositions, family history, or environmental factors. It helps in the early identification of cancer, potentially improving the effectiveness of treatments and increasing the chances of successful outcomes.

The Chromogranin A Test measures levels of chromogranin A, a protein often elevated in neuroendocrine tumors. It helps doctors monitor tumor presence, treatment response, and recurrence. Elevated results may also occur with conditions such as chronic atrophic gastritis, inflammatory diseases, or use of proton pump inhibitors. Combined with imaging and other tumor markers, this test supports the diagnosis and management of neuroendocrine disorders.

The hCG Test with Gestational Table is a blood test that tracks human chorionic gonadotropin to confirm pregnancy and assess fetal growth. Comparing results with gestational reference ranges helps evaluate maternal health, monitor early development, and identify potential complications such as ectopic pregnancy, miscarriage, or abnormal hormone trends linked to reproductive health.

The Hepatic Function Panel without Total Proteins Test measures key liver health markers, including albumin, bilirubin, alkaline phosphatase, ALT, and AST. Doctors use this panel to detect liver disease, monitor damage from hepatitis, alcohol, or medications, and evaluate bile duct function. By excluding total protein, the test focuses on specific enzymes and metabolites that provide insight into liver performance and overall function.

The Total Immunoglobulins Panel measures IgA, IgG, and IgM levels to evaluate immune system function. Abnormal results may indicate immune deficiency, chronic infections, autoimmune disorders, or certain blood cancers. IgA helps protect mucous membranes, IgG provides long-term defense, and IgM is the body’s first response to infection. Doctors use this blood test to diagnose, monitor, and manage immune-related conditions and overall immune health.

The Vascular Endothelial Growth Factor (VEGF) Test measures VEGF levels in blood to assess abnormal blood vessel growth and vascular health. Elevated VEGF may be associated with cancers, macular degeneration, diabetic retinopathy, or inflammatory disorders. Doctors use this test to evaluate angiogenesis activity, investigate unexplained vision changes or tumor growth, and guide treatment strategies for cancer or vascular-related conditions.

 The CA-1 Cancer Screening - Women panel is specifically designed as an initial screening tool for the early detection of various cancers that commonly affect women. This panel combines several tumor markers and protein measurements, each carefully selected for their relevance in detecting specific cancer types. The panel is an important resource for those who are at increased risk of cancer, either due to family history, genetic predisposition, or other risk factors. By measuring specific biomarkers, this panel helps in identifying cancer at an early stage, where treatment can be more effective and less invasive.